Your starter for 10: St George’s is back on University Challenge

The St George’s University Challenge team will be poised with their fingers on the buzzer in next week’s show as they go head to head with Pembroke College, Cambridge, in the first round of the quarter-finals. The team needs to win two quarter-final matches to secure a place in the semi-finals.The show, which has already been recorded, will aired on Monday 18 February BBC2 at 8pm.


Nursing expert backs Francis report calls for patient needs to be at heart of NHS care

Doctors, nurses and healthcare managers must work together to address the issues highlighted in the independent report into the failures of care at Mid Staffordshire NHS Trust, according to a leading healthcare academic. Professor Fiona Ross, dean of the Faculty of Health, Social Care and Education at Kingston University and St George’s, University of London, has welcomed the findings released by inquiry chairman Robert Francis QC. She said his report outlined appalling failures of care that no patient or family should ever have to face.


Principal of St George's, University of London responds to the Francis Inquiry report

Commenting on the publication of the report of the Mid Staffordshire NHS Foundation Trust public enquiry (chaired by Robert Francis QC), Professor Peter Kopelman, Principal of St George’s, University of London said: “St George’s, University of London prides itself on the quality of education and the primacy of the clinical experience it offers its students in health disciplines including medicine.


St George’s and Orphan Technologies enter licensing agreement to create new treatment for rare and deadly disorders

St George’s, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.

St George’s and Orphan aim to develop therapies based on an innovative and highly specialised cell-based enzyme-replacement technology, called Erythrocyte Encapsulated (EE) technology.

Genetically modified tobacco plants produce antibodies to treat rabies

New research shows that genetically modified tobacco plants can be used to produce safe protective antibodies against the deadly rabies virus. This may provide a relatively inexpensive cure for rabies, which would benefit patients in developing countries.

In a new study, scientists produced an antibody in transgenic tobacco plants – plants that have been genetically altered – that was shown to neutralise the rabies virus. This new monoclonal antibody works by preventing the virus from attaching to nerve endings around the bite site and keeps the virus from travelling to the brain. Monoclonal antibodies are complex proteins, originally derived from the body’s immune system but in this case made in the plants, to combat diseases.